Cegedim seeks deeper US coverage

Share this article:
French marketing research giant Cegedim Strategic Data, which gained a US foothold by buying Dendrite International this year, entered an agreement with another US researcher.

The pact with Surveillance Data Inc. is a bid to broaden the firms' reach in longitudinal patient data (LPD) research. The two said they will be able to leverage each other for multinational, anonymized LPD studies using standardized reporting and measurement.

In addition to France, CSD has LPD product coverage in Australia, Belgium, Germany, Italy, Spain, Czech Republic and the United Kingdom. SDI, which specializes in localized illness tracking and modeling data, has US coverage.

LPD, a technique based primarily on secondary data sources, is growing in importance to marketing researchers. Its real value comes when integrated with prescriber data. CSD says it has the ability to merge its primary market research data, including audited promotional data from GPs and specialists, with the LPD studies.  

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.